A study in France on 55&nbsp;women showed that rubbing afimoxifene on the skin was as effective as oral tamoxifen at slowing [[breast cancer]] growth. A United States trial will compare 6 weeks use before breast cancer surgery. Skin application can reduce systemic levels by a factor of nine and this is expected to reduce the unpleasant side-effects of tamoxifen.{{cn|date=April 2017}}
